12:00 AM
Jan 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

CiVentiChem, DFH Pharma deal

DFH selected CRO CiVentiChem to provide "medicinal chemistry services" to support DFH's efforts to develop next-generation HIV maturation inhibitor products. DFH said...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >